Author: Frank Domino, MD in collaboration with Aylin Madore, MD
I stay up-to-date on the latest COVID-19 news and am regularly compiling a list of articles published that are relevant to your primary care practice. Read the insights below from recently published articles in less than two minutes.
To date, many medications remain under investigation: antivirals, immunomodulatory medications, cytokine inhibitors, and other classes.
REGN-COV2 Independent Data Monitoring Committee Recommends Holding Enrollment in Hospitalized Patients with High Oxygen Requirements and Continuing Enrollment in Patients with Low of No Oxygen Requirements
In an October 30th Press Release, Regeneron announced that it recently received the recommendation from the independent data monitoring committee (IDMC) to halt enrollment of patients requiring high flow oxygen or ventilation due to an “unfavorable risk/benefit profile” for its polyclonal antibody cocktail (REGN-COV2). The IDMC further recommended continuing enrollment in hospitalized patients either requiring no or low-flow oxygen.
For more insights, view our collection of COVID-19 resources and CME courses. We recognize it is critical that you have access to timely, reliable information, so we are working hard to release new content in collaboration with our team of infectious disease experts, medical specialists, and primary care clinicians like Dr. Frank Domino.
